Sirius Medical

Speaklee is a company that utilizes AI technology to create a speech assistant tool for children who have difficulties with language, speech, or hearing. It is aimed at enhancing their reading and speaking abilities.

CardiacBooster is a company in the medical field that creates percutaneous devices to assist the left ventricle of the heart.

Plasmacure offers a patented cold plasma solution designed to heal chronic wounds. They provide services in chronic wound healing, cold plasma technology, medical devices for wound care, and treatment for chronic wounds.

Hy2Care® is a company that originated from the MIRA Institute at the University Twente in the Netherlands, a top institute in biomedical and chemical engineering. Over the past decade, significant funding has been dedicated to developing a platform technology, resulting in the filing of multiple patents in Europe and the US. Prototyping and initial animal testing have been successfully carried out. Market research and interviews with prominent orthopedic surgeons have shown a high level of interest in incorporating Hy2Care® products into their practices.

Platos Health is a technology startup dedicated to increasing access to preventive healthcare. Our current focus is on empowering patients to monitor their overall health remotely and providing personalized care for hospitals and clinicians. In the future, we plan to utilize advanced analytics to further expand preventive care to the general population. Platos is supported by investors from well-known organizations and has received recognition for its innovative approach to global health. We have already made significant progress in developing our technology platform, establishing partnerships, and generating clinical evidence, but we understand that building a successful company in the healthcare industry takes time. Our global team operates in a hybrid model with headquarters in Amsterdam and Lagos.

AVIGI Therapeutics is leading the way in creating new drugs through a rational approach that combines advanced chemistry and biotechnology to harness human capabilities.

PROBLEM Insufficient treatment of vulnerable plaque in the coronary arteries lead to costly and health impairing re-catheterizations In 2015, Coronary Artery Disease (CAD) affected 110 million people and resulted in 8.9 million deaths worldwide. CAD occurs when the arteries that supply the heart muscle with blood become hardened and narrowed, due to the buildup of cholesterol and plaque on their inner walls. Current treatment: To open the blocked coronary arteries, 80% of the patients are treated using a Percutaneous Coronary Intervention (PCI). - Of those patients treated with PCI, 12% get a re-catheterization within 12 months after the initial procedure. - Total costs for these re-catheterizations are estimated at $ 3,5 billion. 50% of these re-catheterizations are caused by a type of stenosis called vulnerable plaques, that are formed by fat-filled cells with a thin cover. If the cover ruptures a blood clot is formed, blocking the coronary artery. - If these vulnerable plaques were treated in an early stage, repeat catheterizations could be prevented. SOLUTION Kaminari combines ultrasound (IVUS) and photoacoustic (PA) imaging, providing better information on both plaque location and composition. Visit our website for more details.

Vico Therapeutics specializes in creating RNA-modulating treatments for rare neurological conditions. The company works on developing therapies for disorders affecting the central nervous system, with a primary focus on SCA, HD, and RTT - all disorders that primarily affect the brain and nervous system.

Safe Orthopaedics SA is a French company primarily involved in the medical devices sector, with a focus on creating and selling products designed for spinal surgery.

Yoni is a manufacturing company specializing in the production of tampons, liners, and pads made from organic cotton, and also focuses on discussing reproductive health.

Corporis Medical is a new company in the medical device industry that focuses on creating and marketing advanced medical devices. They also aim to reduce the expenses related to surgeries and procedures for surgeons while enhancing accessibility, closure, and diagnostic measurements.